Roche: FDA approves treatment for allergies

Roche: new collaboration with PathAI in AI

Roche: UBS lowers its price target

Roche: Stifel reduces its price target

Roche Bobois: growth of 5% in annual turnover

Roche: licensing agreement with Remix Therapeutics